“…14 Previously, the same research group demonstrated similar antiatherogenic effects in dyslipidemic patients who were orally administered highdose EPA (1.8 g). 15 In that human study, EPA/arachidonic acid ratios in HDL particles before and after EPA therapy were estimated as 0.4 and 1.25, respectively. 15 The EPA/ arachidonic acid ratios of rHDL (low, 20; intermediate, 80; high, 100) in the present study were 4.9, 72.9, and 257.0, respectively.…”